UNSPSC 51141593: Fosphenytoin sodium

This classification denotes an anticonvulsant agent with the molecular formula C16H13N2O6P.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7VLR55452Z, chemically known as 2,4-imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, disodium salt but more generally known as fosphenytoin sodium, which bears US NIH Compound Identifier 56338. European Medicines Agency schedules Fosphenytoin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13919MIG.

UNSPSC 51141593 Fosphenytoin sodium (Commodity) shows little relevant recent activity in state and local procurement. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and drug deactivation systems for community health use, which falls outside the scope of fosphenytoin sodium, an anticonvulsant pharmaceutical typically used for acute seizure management. The mismatch suggests either a miscoding error in the county's procurement system or a data extraction artifact, rather than active demand for fosphenytoin sodium specifically from state and local buyers.

No state and local contract opportunities for fosphenytoin sodium itself appear in the source material. Vendors monitoring this code should verify whether it reflects actual procurement demand or represents a misconfigured category in their target jurisdictions' systems.